31 results about "Intermittent hypoxia" patented technology

The present invention relates to systems and methods for providing a short-acting analgesic agent in the management of pain during labor, wherein the system enables efficient, real-time prediction of contractions for the coordinated administration of analgesia such that the peak effectiveness of the analgesic coincides with the intermittent pain of labor.

The invention discloses an intermittent hypoxia system, which comprises a sealed box (1), an oxygen concentration measuring and controlling device (2), a nitrogen flow control valve (4) connected to a PLC (3), and an air flow control valve ( 5), the gas replacement control valve (6), the air pump (7), and the oxygen concentration controller (2) in the box are set on the top of the sealed box (1) and away from the sealing cover (11), and the sealed box (1) Nitrogen gas inlets (41, 42) are provided on the left and right side walls of the box, which are connected to the nitrogen gas source (43) connected with the nitrogen flow control valve (4) externally, and the front side wall of the sealed box (1) is provided with an air connection port. The inlet (51) is connected to the air pump (7) with an air flow control valve (5) connected to the outside, and the rear side wall of the sealed box (1) is provided with an air outlet (61), which is connected to the air in the box outside. Displacement control valve (6) is connected. The invention provides an intermittent hypoxia system capable of simulating the experimental environment of intermittent hypoxia.

The invention discloses a small molecule drug and its application in treating intermittent hypoxia, and relates to the technical field of medicine. The drug includes GSK2606414 and milk thistle extract, which can significantly improve hippocampus-dependent cognitive function decline; it has a certain effect on the improvement of hippocampal synaptic plasticity, and can inhibit the activation of the PERK pathway. The drug is administered in the amount of 45-55 mg / kg of GSK2606414 and 32.4-50 mg / kg of milk thistle extract per day, administered once a day or divided into 2-4 times, taking 12-14 days or longer.

The invention relates to an experimental animal feeding cabin, in particular to a vertical lifting intermittent hypoxia rat and mouse feeding cabin, which comprises feeding cages, hypoxia feeding cabins formed by closed cabin bodies and buffer cabins formed by closed cabin bodies. An isolating cabin door is arranged between each buffer cabin and each hypoxia feeding cabin. The buffer cabins are overlaid on the hypoxia feeding cabins. A buffer cabin door is arranged at the top of each buffer cabin. The feeding cages are respectively arranged above the hypoxia feeding cabins and the buffer cabins. A feeding cage lifting driving device drives the feeding cages to periodically pass through the buffer cabins to get in and out of the hypoxia feeding cabins. Since the feeding cages, the buffer cabins and the hypoxia feeding cabins are vertically arranged and the feeding cages are driven to be lifted up and lowered down by using the feeding cage lifting driving device, the vertical lifting intermittent hypoxia rat and mouse feeding cabin has the advantages that the occupied area is smaller, the field utilization ratio is higher, the noise is low, the manufacturing of linear tracks is not needed, the structure is compact, the working reliability is higher, the feeding cabin is convenient to control and the manufacturing cost is lower.

The invention discloses a novel use of low-oxygen system used for the treatment of myocardial ischemia and myocardial infarction. The invention also discloses the application of oxygen in the manufacture of myocardial ischemia and myocardial infarction treatment equipments. The invention also discloses a method of treating mammal's myocardial ischemia and myocardial infarction using intermittent low oxygen dealing to carrying out treatment. The invention proves that the intermittent low oxygen dealing has significant therapeutic effect for big mouse myocardial ischemia and myocardial infarction; it provides new approach for clinical therapeutic of myocardial ischemia and myocardial infarction as a new interfere therapeutic means.

The invention relates to an experimental animal feeding cabin, which is the big and small mice feeding cabin for simulating the symptom of intermittent anaerobic respiration of animal. One side of hypoxia feeding cabin is further connected with a buffering cabin formed from a closed cabin body and a feeding cage track such that the feeding cabin loading the big mouse is timed to stay between the hypoxia feeding cabin and the outside along the feeding cage track so as to simulate the big mouse model of SAS by the long-period intermittent breathing hypoxia gas. There is no need to timely and frequently discharge the nitrogen in the hypoxia feeding cabin, thus, the consumption quantity of the nitrogen is greatly reduced and the experiment cost is reduced by a wide margin.

The invention discloses a device and method for treating low-carbon urban sewage through synchronization of anaerobic ammonia oxidation coupling denitrifying phosphorus removal and endogenous denitrification, and belongs to the field of biological sewage treatment. Urban sewage enters an endogenous denitrification coupling dephosphorization SBR reactor for anaerobic stirring, energy is provided for glycogen inside denitrification glycogen-accumulating organisms decomposition cells, volatile fatty acid VFA in sewage is absorbed for synthesizing an internal carbon source PHA to be stored into the body, meanwhile, the denitrification phosphate-accumulating organisms are subjected to anaerobic phosphorus release, and VFA in the sewage is absorbed for synthesizing PHA to be stored into the body; after anaerobic stirring is finished, precipitation and drainage are performed, outlet water is drained into a middle water tank; then, water containing ammonia nitrogen and phosphate in the middle water tank is made to enter an integrated partial nitrification anaerobic ammonia oxidation SBR reactor, intermittent hypoxia aeration stirring is performed, and water is drained and drained into a water outlet tank; the outlet water of the integrated partial nitrification anaerobic ammonia oxidation SBR reactor is made to enter the endogenous denitrification coupling dephosphorization SBR reactor for hypoxia aeration stirring. According to the method, organic carbon sources in raw water are efficiently utilized, and the aeration rate is saved.

The invention relates to an experimental animal feeding cabin, which is the big and small mice feeding cabin for simulating the symptom of intermittent anaerobic respiration of animal. One side of hypoxia feeding cabin is further connected with a buffering cabin formed from a closed cabin body and a feeding cage track such that the feeding cabin loading the big mouse is timed to stay between the hypoxia feeding cabin and the outside along the feeding cage track so as to simulate the big mouse model of SAS by the long-period intermittent breathing hypoxia gas. There is no need to timely and frequently discharge the nitrogen in the hypoxia feeding cabin, thus, the consumption quantity of the nitrogen is greatly reduced and the experiment cost is reduced by a wide margin.

The present invention relates to the construction of an animal model, specifically a method for establishing a mouse model of obstructive sleep apnea with aortic dissection. In the method, a subcutaneous pump is used to continuously perfuse angiotensin II in an intermittent hypoxia simulation chamber to establish a mouse model. Animal model, the method of the present invention establishes a mouse model of obstructive sleep apnea with aortic dissection, which combines the IHR curve of an adult patient with simulated severe OSAS and the AD mouse model induced by Ang II to evaluate this new mouse model Finally, we were able to demonstrate that the IH group had a higher rate of AD formation, a larger maximum aortic diameter, and a lower cumulative survival rate than the control group. These phenotypic data are consistent with findings in humans. Therefore, we established a reliable and easy-to-use mouse model to study the role of OSAS in AD.